BRIEF published on 08/14/2024 at 07:36, 2 years 2 months ago MLP Sets New Record for Revenue and Earnings in H1 2024 Revenue Growth Wealth Management Financial Forecast 2024 Earnings MLP Group
PRESS RELEASE published on 08/14/2024 at 07:31, 2 years 2 months ago H1 2024: MLP sets new record for both revenue and earnings MLP SE achieves record revenue and earnings in H1 2024, EBIT reaches EUR 48.7 million. Revenue growth in wealth management & interest rate business. Assets under management at EUR 60.5 billion. EBIT forecast for 2024 confirmed EBIT Record Revenue Earnings MLP SE H1 2024
BRIEF published on 07/30/2024 at 09:26, 2 years 2 months ago NuWays AG Reiterates 'BUY' Recommendation for MLP SE Following Robust Q2 Results MLP SE Performance Fees Investment Guidance Q2 EBIT Banking Income
PRESS RELEASE published on 07/30/2024 at 09:21, 2 years 2 months ago Original-Research: MLP SE (von NuWays AG): BUY NuWays AG releases research updating MLP SE classification, with Q2 EBIT above estimates and guidance at upper end. Analyst Henry Wendisch recommends BUY with PT of EUR 11.50 Buy Recommendation NuWays AG EUR 11.50 MLP SE EBIT Estimates
BRIEF published on 07/29/2024 at 14:24, 2 years 2 months ago MLP Group Sees Significant EBIT Increase in Q2 2024 Wealth Management Preliminary Results MLP SE Q2 2024 EBIT Increase
PRESS RELEASE published on 07/29/2024 at 14:19, 2 years 2 months ago EQS-Adhoc: MLP SE: Q2 2024: Preliminary EBIT of the MLP Group significantly above previous year's level MLP SE reports a significant increase in preliminary EBIT to EUR 12 million for Q2 2024, attributed to positive operational development and increase in Wealth competence MLP SE Assets Under Management Q2 2024 Preliminary EBIT Wealth Competence
BRIEF published on 07/11/2024 at 09:07, 2 years 3 months ago MLP SE Expected to Collect €4.2m in Performance Fees in Q2 Asset Management MLP SE Analyst Recommendation Performance Fees FERI
PRESS RELEASE published on 07/11/2024 at 09:02, 2 years 3 months ago Original-Research: MLP SE (von NuWays AG): Buy MLP SE updated research by NuWays AG expects €4.2m performance fees from public funds in Q2'24, driven by Optoflex & Euro Equity Flex. BUY recommendation remains with PT of €11.50 Buy Recommendation NuWays AG MLP SE Q2 2024 Performance Fees
BRIEF published on 06/04/2024 at 09:06, 2 years 4 months ago MLP SE: NuWays AG Recommends Buy with Target Price of €11.50 Real Estate Wealth Management NuWays AG MLP SE ECB Rate
PRESS RELEASE published on 06/04/2024 at 09:01, 2 years 4 months ago Original-Research: MLP SE (von NuWays AG): Kaufen MLP SE update: NuWays AG's research highlights potential ECB rate reduction impact on banking, wealth management, & real estate. Analyst recommends buying with target price of EUR 11.50 Real Estate Wealth Management NuWays AG MLP SE ECB Rate Reduction
Published on 10/19/2026 at 23:20, 4 hours 22 minutes ago CoTec Holdings Corp. Announces Investor Awareness Agreements
Published on 10/19/2026 at 23:00, 4 hours 42 minutes ago Eskay Mining Corp. Announces Results of Annual Meeting
Published on 10/19/2026 at 22:50, 4 hours 52 minutes ago Bluesky Digital Announces Termination of ChessGold Inc. Transaction and Management and Director Changes
Published on 10/19/2026 at 22:01, 5 hours 41 minutes ago Unusual Machines Completes Acquisition of Upgrade Energy, Expanding U.S. Drone Battery Manufacturing
Published on 10/19/2026 at 22:16, 5 hours 26 minutes ago EQS-Adhoc: Pentixapharm Holding AG: 2026 Earnings Guidance Raised; First-Patient Enrollment in PANDA Phase 3 Study Now Expected in the First Quarter of 2027
Published on 10/19/2026 at 21:22, 6 hours 20 minutes ago EQS-Adhoc: Cantourage Group SE: Supervisory Board Resolves to Transition to IFRS Following First-Time Requirement to Prepare Consolidated Financial Statements
Published on 10/19/2026 at 18:05, 9 hours 37 minutes ago Cognizant and Google Cloud Expand Alliance to Accelerate Agentic Enterprise Transformation
Published on 10/19/2026 at 17:45, 9 hours 57 minutes ago VALBIOTIS SA: Valbiotis receives double “Best Pharma Product 2027” award for its ValbiotisPRO® Cholestérol and ValbiotisPRO® Santé Métabolique solutions
Published on 10/19/2026 at 17:30, 10 hours 12 minutes ago GEVELOT S.A.: Weekly declaration of share buybacks – 10/19/2026 (French only)
Published on 10/19/2026 at 18:40, 9 hours 2 minutes ago Reporting on share buyback transactions carried out between October 12 and October 13, 2026
Published on 10/19/2026 at 18:00, 9 hours 42 minutes ago WHO Grants Emergency Use Listing for BIOFIRE® Global Fever Special Pathogens Panel, Expanding Access to Differential Diagnostics for the Ebola Response
Published on 10/19/2026 at 17:45, 9 hours 57 minutes ago Declaration of transactions on own shares from October 12, 2026 to October 18, 2026
Published on 10/19/2026 at 17:40, 10 hours 2 minutes ago Schneider Electric launches a c. €6.0 billion capital increase, without shareholders’ preferential subscription rights, to partially finance the acquisition of PTC Inc.
